Crescent Biopharma, Inc. - PE Ratio

The PE Ratio as of June 2026 (TTM) for Crescent Biopharma, Inc. (CBIO) is -3.01

According to Crescent Biopharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.01. This represents a change of 15.11% compared to the average of -2.61 of the last 4 quarters.

Crescent Biopharma, Inc. (CBIO) Historical PE Ratio (quarterly & annually)

How has CBIO PE Ratio performed in the past?

The mean historical PE Ratio of Crescent Biopharma, Inc. over the last ten years is -430.85. The current -3.01 PE Ratio has changed -30.14% with respect to the historical average. Over the past ten years (40 quarters), CBIO's PE Ratio was at its highest in in the December 2025 quarter at -0.74. The PE Ratio was at its lowest in in the June 2018 quarter at -1550.96.

Crescent Biopharma, Inc. (CBIO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Crescent Biopharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Crescent Biopharma, Inc. (CBIO) Average PE Ratio

How has CBIO PE Ratio performed in the past?

The current PE Ratio of Crescent Biopharma, Inc. (CBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Crescent Biopharma, Inc. (CBIO) PE Ratio vs. Peers

How is CBIO’s PE Ratio compared to its peers?

Crescent Biopharma, Inc.’s PE Ratio is less than Compugen Ltd. (5.48), greater than C4 Therapeutics, Inc. (-3.49), less than Sangamo Therapeutics, Inc. (-0.45), greater than Insight Molecular Diagnostics Inc. (-3.59), less than Armata Pharmaceuticals, Inc. (-0.91), less than Tonix Pharmaceuticals Holding Corp. (-0.82), less than Vyome Holdings, Inc. (-0.06), less than Heron Therapeutics, Inc. (-2.36), less than Innate Pharma S.A. (-2.92), greater than OmniAb, Inc. (-5.09),

Build a custom stock screener for Crescent Biopharma, Inc. (CBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crescent Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Crescent Biopharma, Inc. (CBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Crescent Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.